Björn Oskarrson

New Capabilities

Study co-author, reported results September 2026

A physician with rare inherited ALS received a drug built around his own gene mutation, the first therapy designed for this genetic form of the disease. A year after his first dose, his neuron-damage biomarker fell into the normal range and he kept practicing medicine.

Updated 3 hours ago